Abstract:Breast cancer (BC) is the second-largest cause of cancer-related deaths among women worldwide. The development of BC is a complex and multi-step process involving multiple cell types, creating a real challenge for the development of potential therapeutics against it. Several researchers have demonstrated that JNK family members have been associated with BC regulation and progression. In general, JNK is phosphorylated and activated by a number of upstream kinases, and phospho-JNK regulates a variety of cellular functions by phosphorylating c-Jun and other downstream targets. Thus, JNK has become a vital target for the development of potential therapeutics for BC treatment. In past years, electrosynthesis has emerged as a fascinating area superior to traditional chemical processes, as the evolved electrochemical technologies function at higher reaction rates for the synthesis of desired compounds. In this study, we have synthesized a series of triazole compounds using both conventional and electrochemical methods for targeting JNK in human BC cells. All the synthesized molecules were preliminarily evaluated for a cytotoxicity study against MCF-7 cells and the compound 1-(3,4-dichlorophenyl)-4-(((4-isopropyl-5-(4-methoxybenzyl)-4 H -1,2,4-triazol-3-yl)thio)methyl)-1 H -1,2,3-triazole ( 5b ) is the most potent candidate among the series based on its lower inhibition concentration (IC 50 ) of 4.78 μM. Further studies were performed to evaluate the anticancer potential of novel 5b in human BC cells and the results showed that 5b significantly inhibited colony formation, migration and induced apoptosis by increasing the expression of pro-apoptotic protein BAX, and inhibiting the anti-apoptotic protein BCL2. Furthermore, the novel 5b also induced the phosphorylation of JNK in BC cells in a dose-dependent manner. Additionally, an in silico docking study revealed that compound 5b has a strong binding affinity (−8.88 kcal mol −1 ) towards JNK3S. In conclusion, the novel synthesized compound 5b triggers apoptosis and JNK phosphorylation in BC cells, and may provide a new and potent therapeutic strategy against BC.

Discovery of Piperazin‐2‐yl‐pyrimidines as Anticancer Agents via Targeting JNK Signaling Pathway in Human MCF‐7 Breast Carcinoma

Design, Synthesis and In‐Silico Studies of Piperidine‐Dihydropyridine Hybrids as Anticancer Agents

Discovery of Pyrimidine- and Coumarin-Linked Hybrid Molecules As Inducers of JNK Phosphorylation Through ROS Generation in Breast Cancer Cells.

Synthesis of novel triazoles as anticancer agents targeting pJNK in human breast cancer cells

Synthesis, DFT, ADMET, and Docking studies of Novel Sulfonyl Piperidine Analogues containing 2,3-Dihydrobenzofuran-5-Carboxamide

Design, synthesis and molecular docking of novel 4-morpholino-1 H -pyrrolo[2,3- b ] pyridine-5-carboxamides and 4-methylpiperazin-1 H -pyrrolo[2,3- b ] pyridine-5-carboxamides for the evaluation anti-cancer activity

Development of Novel 1,3,4‐Trisubstituted Pyrazole Derivatives Bearing Sulfonamide Moiety as Anticancer Agents Targeting JNK Kinases

New Imidazo[4,5‐c]pyridine‐piperidine Hybrids as Potential Anti‐cancer Agents and In‐Silico Studies

Novel 3,6-Disubstituted Pyridazine Derivatives Targeting JNK1 Pathway: Scaffold Hopping and Hybridization-Based Design, Synthesis, Molecular Modeling, and In Vitro and In Vivo Anticancer Evaluation

Development of Piperazine- and Oxazine-Linked Pyrimidines As P65 Subunit Binders of NF–κB in Human Breast Cancer Cells

Structure-based Design and Synthesis of Imidazo[1,2-A]pyridine Derivatives As Novel and Potent Nek2 Inhibitors with in Vitro and in Vivo Antitumor Activities

Computational Design, Chemical Synthesis, and Bioevaluation of Pyrimidinyl‐Indoles for Targeting Breast Cancer Cells

Design and synthesis of N-(1-(6-(substituted phenyl)-pyridazin-3-yl)-piperidine-3-yl)-amine derivatives as JMJD6 inhibitors

Combined computational and synthetic strategies for the development of potent pyrazolo-pyridine derivatives as anticancer agents

Design and synthesis of a C7-aryl piperlongumine derivative with potent antimicrotubule and mutant p53-reactivating properties

Synthesis, Biological Evaluation and Molecular Docking Study of Novel Benzhydryl Piperazine‐1,2,3‐Triazoline Hybrids

Design, synthesis and biological evaluation of novel tetrahydrothieno [2,3-c]pyridine substitued benzoyl thiourea derivatives as PAK1 inhibitors in triple negative breast cancer

Synthesis of novel piperazine-based bis(thiazole)(1,3,4-thiadiazole) hybrids as anti-cancer agents through caspase-dependent apoptosis

Synthesis and Biological Evaluation of Novel Pyrazoline Derivatives Containing Indole Skeleton As Anti-Cancer Agents Targeting Topoisomerase II.

Discovery of oxazine-linked pyrimidine as an inhibitor of breast cancer growth and metastasis by abrogating NF-κB activation

Design and Synthesis of Indole Pyrimidine Scaffolds as Potential KSP Inhibitors and Anticancer Agents